Literature DB >> 17387151

Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.

Catherine S McVay1, Marisela Velásquez, Joe A Fralick.   

Abstract

Mice compromised by a burn wound injury and subjected to a fatal infection with Pseudomonas aeruginosa were administered a single dose of a Pseudomonas aeruginosa phage cocktail consisting of three different P. aeruginosa phages by three different routes: the intramuscular (i.m.), subcutaneous (s.c.), or intraperitoneal (i.p.) route. The results of these studies indicated that a single dose of the P. aeruginosa phage cocktail could significantly decrease the mortality of thermally injured, P. aeruginosa-infected mice (from 6% survival without treatment to 22 to 87% survival with treatment) and that the route of administration was particularly important to the efficacy of the treatment, with the i.p. route providing the most significant (87%) protection. The pharmacokinetics of phage delivery to the blood, spleen, and liver suggested that the phages administered by the i.p. route were delivered at a higher dose, were delivered earlier, and were delivered for a more sustained period of time than the phages administered by the i.m. or s.c. route, which may explain the differences in the efficacies of these three different routes of administration.

Entities:  

Mesh:

Year:  2007        PMID: 17387151      PMCID: PMC1891379          DOI: 10.1128/AAC.01028-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.

Authors:  C S Vinodkumar; Y F Neelagund; Suneeta Kalsurmath
Journal:  J Commun Dis       Date:  2005-03

3.  Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.

Authors:  Jing Wang; Bei Hu; Minchao Xu; Qun Yan; Shuangyou Liu; Xuhui Zhu; Ziyong Sun; Deding Tao; Li Ding; Eddie Reed; Jianping Gong; Qingdi Q Li; Junbo Hu
Journal:  Int J Mol Med       Date:  2006-02       Impact factor: 4.101

Review 4.  Phage therapy: facts and fiction.

Authors:  Mikael Skurnik; Eckhard Strauch
Journal:  Int J Med Microbiol       Date:  2005-11-15       Impact factor: 3.473

Review 5.  Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.

Authors:  Shigenobu Matsuzaki; Mohammad Rashel; Jumpei Uchiyama; Shingo Sakurai; Takako Ujihara; Masayuki Kuroda; Masahiko Ikeuchi; Toshikazu Tani; Mikiya Fujieda; Hiroshi Wakiguchi; Shosuke Imai
Journal:  J Infect Chemother       Date:  2005-10       Impact factor: 2.211

6.  Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections.

Authors:  K P Rumbaugh; J A Griswold; B H Iglewski; A N Hamood
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally.

Authors:  R Capparelli; I Ventimiglia; S Roperto; D Fenizia; D Iannelli
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

Review 8.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

9.  In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.

Authors:  Lia Danelishvili; Lowell S Young; Luiz E Bermudez
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

10.  The third age of phage.

Authors:  Nicholas H Mann
Journal:  PLoS Biol       Date:  2005-05-17       Impact factor: 8.029

View more
  93 in total

1.  Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples.

Authors:  S Kumari; K Harjai; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

2.  Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments.

Authors:  A Vieira; Y J Silva; A Cunha; N C M Gomes; H-W Ackermann; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-10       Impact factor: 3.267

3.  Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.

Authors:  Kimberley D Seed; Jonathan J Dennis
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

4.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

Authors:  Lisa A Carmody; Jason J Gill; Elizabeth J Summer; Uma S Sajjan; Carlos F Gonzalez; Ryland F Young; John J LiPuma
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

5.  Experimental phage therapy of burn wound infection: difficult first steps.

Authors:  Thomas Rose; Gilbert Verbeken; Daniel De Vos; Maya Merabishvili; Mario Vaneechoutte; Rob Lavigne; Serge Jennes; Martin Zizi; Jean-Paul Pirnay
Journal:  Int J Burns Trauma       Date:  2014-10-26

Review 6.  Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Diana P Pires; Diana Vilas Boas; Sanna Sillankorva; Joana Azeredo
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

7.  Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.

Authors:  In-Young Chung; Nuri Sim; You-Hee Cho
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

8.  Characterization of five newly isolated bacteriophages active against Pseudomonas aeruginosa clinical strains.

Authors:  Magdalena Kwiatek; Lidia Mizak; Sylwia Parasion; Romuald Gryko; Alina Olender; Marcin Niemcewicz
Journal:  Folia Microbiol (Praha)       Date:  2014-07-04       Impact factor: 2.099

9.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

Review 10.  Comparative transcriptome analyses of Pseudomonas aeruginosa.

Authors:  Deepak Balasubramanian; Kalai Mathee
Journal:  Hum Genomics       Date:  2009-07       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.